← All stocks

Stock news timeline · COHANCE

Cohance Lifesciences

News timeline · Last 30 days

24 Aug 2026 – 22 Sep 2026 · Times in IST

Timeline updates
12
Bullish
6
Neutral
6
Bearish
0
Active days
7

News timeline

Showing 12 of 12 updates · Newest first

Monday, 21 Sep 20264 updates

AI sentiment: Bullish 69% confidence

Cohance Jumps 5.5% Despite USFDA Observations, Plans $18M ADC Investment

Cohance Lifesciences shares rose 5.5% despite USFDA issuing five observations at its Andhra API unit. Cohance initiated CAPAs, plans $18M ADC investments, and its stock trades at ₹460.2, up 50% in six months. Source: CNBC TV 18

AI sentiment: Neutral 77% confidence

Cohance Life Sends $10M for NJ Bio Deal; NDTV Flags Stock in Focus

Cohance Life remitted $10M for CCPS subscription of NJ Bio, part of Shilpa Medicare. NDTV Profit lists Cohance Life among stocks in focus before market open. Source: NDTV Profit

AI sentiment: Bullish 79% confidence

Cohance Lifesciences: Jaggaiahpet API Facility Passes USFDA Inspection With Five Noted Observations.

AI sentiment: Bullish 54% confidence

Cohance Lifesciences Gets 5 USFDA Observations; CAPA Underway

Cohance Lifesciences' API facility in Andhra Pradesh underwent USFDA inspection from 14-19 Sep 2026. Inspection ended with 5 observations; CAPA initiated, and response will be submitted promptly. Source: BSE

Friday, 18 Sep 20261 update

AI sentiment: Neutral 82% confidence

Cohance Lifesciences Invests $10M in ADC Tech Firm NJ Bio

Cohance Lifesciences invests $10M in NJ Bio, a CRDMO specializing in ADC tech. NJ Bio's turnover: $20.6M (2023), $32.6M (2024 est.), $23.5M (2025 est.). Source: ScoutQuest

Thursday, 17 Sep 20261 update

AI sentiment: Neutral 84% confidence

Cohance Lifesciences Completes AGM; Key Resolutions Passed

Cohance Lifesciences held its 8th AGM on 17 Sep 2026 via VC/OAVM, completing all listed business items. Resolutions on financial statements and director reappointment were passed with requisite majority; voting details shared publicly. Source: BSE

Saturday, 05 Sep 20263 updates

AI sentiment: Bullish 63% confidence

Cohance Lifesciences Gets 4 USFDA Observations, Plans Corrective Action

Cohance Lifesciences completes USFDA inspection, receives 4 observations on Form 483. The company plans to initiate corrective actions and respond to the observations promptly. Source: Livesquawk

AI sentiment: Bullish 74% confidence

Cohance Lifesciences: Finishes USFDA Inspection At Plant; Receives Four Observations On FDA Form 483; Plans To Start Corrective Measures And Respond Promptly.

AI sentiment: Neutral 88% confidence

USFDA Issues Form 483 for Cohance Lifesciences' Telangana Plant; CAPA Underway

Cohance Lifesciences' Telangana FDF plant inspected by USFDA, 27 Aug-4 Sep 2026. Inspection ended with Form FDA 483; firm initiating CAPA and response submission. Source: BSE

Thursday, 03 Sep 20261 update

AI sentiment: Bullish 86% confidence

Cohance Lifesciences Invests $18M in NJ Bio & Aruka Bio to Boost ADC Strategy

Cohance Lifesciences approved investments in NJ Bio and Aruka Bio, totaling USD 18M, to strengthen its ADC strategy. The reorganization increases Cohance's stake in NJ Bio to 67.3% and grants 65% control of Aruka Bio, enhancing integration and pipeline development. Source: BSE

Thursday, 27 Aug 20261 update

AI sentiment: Neutral 93% confidence

Cohance Lifesciences: Plans Meeting With Analysts And Investors On September 1

Wednesday, 26 Aug 20261 update

AI sentiment: Neutral 59% confidence

Cohance Life Sees ₹46.35 Cr Block Deal on BSE at ₹463.5/Share

Cohance Life saw a Rs 46.35 cr BSE block trade for 1,000,045 shares at Rs 463.5/share. Source: Livesquawk